4//SEC Filing
LIPOSCIENCE INC 4
Accession 0001127602-14-033303
CIK 0001168197operating
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 3:15 PM ET
Size
19.0 KB
Accession
0001127602-14-033303
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
Otvos James D.
EVP, Chief Scientific Officer
Transactions
- Disposition to Issuer
Common Stock
2014-11-20$5.25/sh−180,167$945,877→ 0 total(indirect: By Spouse) - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$1.37/sh−16,160$22,139→ 0 totalExercise: $3.88Exp: 2017-02-15→ Common Stock (16,160 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$2.79/sh−52,380$146,140→ 0 totalExercise: $2.46Exp: 2017-10-25→ Common Stock (52,380 underlying) - Disposition to Issuer
Common Stock
2014-11-20$5.25/sh−504,771$2,650,048→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$2.75/sh−2,000$5,500→ 0 totalExercise: $2.50Exp: 2015-05-05→ Common Stock (2,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$2.79/sh−6,308$17,599→ 0 totalExercise: $2.46Exp: 2018-04-29→ Common Stock (6,308 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$2.75/sh−19,254$52,949→ 0 totalExercise: $2.50Exp: 2019-02-06→ Common Stock (19,254 underlying)
Footnotes (12)
- [F1]Disposed of pursuant to the Merger Agreement and includes 23,151 shares of the Issuer's common stock underlying restricted stock unit awards.
- [F10]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $17,639.69, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F11]The option was fully vested upon issuance on February 6, 2009.
- [F12]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $53,048.62, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F2]Disposed of pursuant to the Merger Agreement.
- [F3]The option was fully vested upon issuance on May 5, 2005.
- [F4]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $5,510.40, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F5]The option was fully vested upon issuance on February 15, 2007.
- [F6]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $22,198.99, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F7]The option was fully vested upon issuance on October 25, 2007.
- [F8]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $146,475.44, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F9]The option was fully vested upon issuance on April 29, 2008.
Documents
Issuer
LIPOSCIENCE INC
CIK 0001168197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001168197
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 3:15 PM ET
- Size
- 19.0 KB